Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

November 1, 2013

Primary Completion Date

February 1, 2015

Study Completion Date

February 6, 2015

Conditions
Anaemia
Interventions
DRUG

GSK1278863

Film coated tablets containing 1 mg, 2 mg, 5 mg, or 25 mg of GSK1278863

DRUG

Placebo

Matching placebo tablet for GSK1278863

DRUG

rhEPO

rhEPO will be procured from local market

Trial Locations (107)

1115

GSK Investigational Site, Budapest

2145

GSK Investigational Site, Westmead

2170

GSK Investigational Site, Liverpool

2500

GSK Investigational Site, Esztergom

3116

GSK Investigational Site, Tønsberg

4011

GSK Investigational Site, Stavanger

4102

GSK Investigational Site, Woolloongabba

5000

GSK Investigational Site, Adelaide

GSK Investigational Site, Odense C

6009

GSK Investigational Site, Nedlands

7006

GSK Investigational Site, Trondheim

7624

GSK Investigational Site, Pécs

7633

GSK Investigational Site, Pécs

10461

GSK Investigational Site, The Bronx

12053

GSK Investigational Site, Berlin

14004

GSK Investigational Site, Córdoba

14033

GSK Investigational Site, Caen

14226

GSK Investigational Site, Amherst

15706

GSK Investigational Site, Santiago de Compostela

17109

GSK Investigational Site, Demmin

18014

GSK Investigational Site, Granada

20814

GSK Investigational Site, Bethesda

22297

GSK Investigational Site, Hamburg

28007

GSK Investigational Site, Madrid

28224

GSK Investigational Site, Madrid

28702

GSK Investigational Site, San Sebastián de los Reyes

28805

GSK Investigational Site, Alcalá de Henares

31217

GSK Investigational Site, Macon

33000

GSK Investigational Site, Bordeaux

33028

GSK Investigational Site, Pembroke Pines

33313

GSK Investigational Site, Lauderdale Lakes

37923

GSK Investigational Site, Knoxville

39008

GSK Investigational Site, Santander

40210

GSK Investigational Site, Düsseldorf

60805

GSK Investigational Site, Evergreen Park

63640

GSK Investigational Site, Farmington

68167

GSK Investigational Site, Mannheim

75743

GSK Investigational Site, Paris

76502

GSK Investigational Site, Temple

78229

GSK Investigational Site, San Antonio

80054

GSK Investigational Site, Amiens

81675

GSK Investigational Site, Munich

90022

GSK Investigational Site, Los Angeles

90025

GSK Investigational Site, Los Angeles

91307

GSK Investigational Site, West Hills

91702

GSK Investigational Site, Azusa

91773

GSK Investigational Site, San Dimas

125101

GSK Investigational Site, Moscow

141009

GSK Investigational Site, Mytischi

143400

GSK Investigational Site, Krasnogorsk

150062

GSK Investigational Site, Yaroslavl

191104

GSK Investigational Site, Saint Petersburg

194354

GSK Investigational Site, Saint Petersburg

248007

GSK Investigational Site, Kaluga

350029

GSK Investigational Site, Krasnodar

630087

GSK Investigational Site, Novosibirsk

Unknown

GSK Investigational Site, Charlotte

T2R 0X7

GSK Investigational Site, Calgary

T6G 2B7

GSK Investigational Site, Edmonton

P3E 5J1

GSK Investigational Site, Greater Sudbury

N2G 1G3

GSK Investigational Site, Kitchener

N6A 5A5

GSK Investigational Site, London

H1T 2M4

GSK Investigational Site, Montreal

460 63

GSK Investigational Site, Liberec

440 01

GSK Investigational Site, Louny

434 64

GSK Investigational Site, Most

100 34

GSK Investigational Site, Prague

128 08

GSK Investigational Site, Prague

142 00

GSK Investigational Site, Prague

356 01

GSK Investigational Site, Sokolov

DK-4000

GSK Investigational Site, Roskilde

04129

GSK Investigational Site, Leipzig

441-8023

GSK Investigational Site, Aichi

790-0952

GSK Investigational Site, Ehime

790-0962

GSK Investigational Site, Ehime

803-0844

GSK Investigational Site, Fukuoka

617-0813

GSK Investigational Site, Kyoto

940-0053

GSK Investigational Site, Niigata

640-8335

GSK Investigational Site, Wakayama

990-0834

GSK Investigational Site, Yamagata

0027

GSK Investigational Site, Oslo

0405

GSK Investigational Site, Oslo

31-501

GSK Investigational Site, Krakow

33-100

GSK Investigational Site, Tarnów

02-507

GSK Investigational Site, Warsaw

41-800

GSK Investigational Site, Zabrze

431-070

GSK Investigational Site, Anyang-Si Gyeonggi-do

700-721

GSK Investigational Site, Daegu

301-721

GSK Investigational Site, Daejeon

501-757

GSK Investigational Site, Gwangju

405-760

GSK Investigational Site, Incheon

120-752

GSK Investigational Site, Seoul

03010

GSK Investigational Site, Alicante

04009

GSK Investigational Site, Almería

08916

GSK Investigational Site, Badalona

08907

GSK Investigational Site, Barcelona

SE-651 85

GSK Investigational Site, Karlstad

SE-701 85

GSK Investigational Site, Örebro

SE-141 86

GSK Investigational Site, Stockholm

SE-751 85

GSK Investigational Site, Uppsala

CM1 7ET

GSK Investigational Site, Chelmsford

DT1 2JY

GSK Investigational Site, Dorchester

DD1 9SY

GSK Investigational Site, Dundee

HU3 2JZ

GSK Investigational Site, Hull

E1 1BB

GSK Investigational Site, London

M13 9WL

GSK Investigational Site, Manchester

OX3 7LE

GSK Investigational Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY